Herpes zoster recurrences more frequent than previously reported

Mayo Clinic Proceedings

Volumn 86, Issue 2, 2011, Pages 88-93

  Yawn, Barbara P ^a   Wollan, Peter C ^a   Kurland, Marge J ^a   St Sauver, Jennifer L ^b   Saddier, Patricia ^c  

^a OLMSTED MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMISED PATIENT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PAIN; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RECURRENT INFECTION; SEX DIFFERENCE;

EID: 79551676833     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0618     Document Type: Article

References (28)

1. Chien AJ, Olerud JE. Why do so many clinicians believe that recurrent zoster is common? Dermatol Online J. 2007;13(2):2.
2. Heskel NS, Hanifin JM. "Recurrent herpes zoster": an unproved entity? J Am Acad Dermatol. 1984;10(3):486-490.
3. Horiuchi Y. Recurrent herpes zoster. J Dermatol. 1998;25(5):347-348.
4. Burkhart CN. Recurrent herpes zoster revisited [letter]. Int J Dermatol. 2002;41(8):528.
5. Bansal R. Recurrent herpes zoster. Int J Dermatol. 2001;40(8):542-543.
6. Cerny Z. Recurrent eruptions of herpes zoster [in Czech]. Bratisl Lek Listy (Tlacene Vyd). 1999;100(9):515-518.
7. Schwickert M, Saha J. Recurrent herpes zoster with neuralgia [in German]. Forsch Komplement Med. 2006;13(3):184-186.
8. Bruning AH, Samie MH. Recurrent herpes zoster and high-dose inhaled steroids for asthma [letter]. S Afr Med J. 1994;84(12):873.
9. Cvjetković D, Jovanović J, Hrnjaković- Cvjetković I, Brkić S, Bogdanović (3)M. Reactivation of herpes zoster infection by varicella-zoster virus [in Croatian]. Med Pregl. 1999;52(3-5):125-128.
10. Epstein E. Recurrences in herpes zoster. Cutis. 1980;26(4):378-379.
11. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20.
12. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population- based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310-316.
13. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605-1609.
14. Bowsher D. The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain. 1999;3(4):335-342.
15. Helgason S, Sigurdsson JA, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pract. 1996;2(1):12-15.
16. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271- 2284.
17. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341-1349.
18. Giehl KA, Müller-Sander E, Rottenkolber M, Degitz K, Volkenandt M, Berking C. Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection. J Eur Acad Dermatol Venereol. 2008;22:722-728.
19. Harbecke R, Oxman M, Arnold B, et al. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol. 2009;81:1310-1322.
20. Kalman C, Laskin O. Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med. 1986;81:775-778.
21. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30.
22. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71(3):266-274.
23. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54-63.
24. Yawn BP, Wollan P. Interrater reliability: completing the methods description in medical records review studies. Am J Epidemiol. 2005;161(10):974-977.
25. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526. http://www.escarela. com/archivo/anahuac/03o/coxdiag.pdf. Accessed November 11, 2010.
26. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44(suppl 1):S1-S26.
27. Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135(6):908-913.
28. Hicks LD, Cook-Norris RH, Mendoza N, Madkan V, Arora A, Tyring SK. Family history as a risk factor for herpes zoster: a case-control study. Arch Dermatol. 2008;144(5):603-608.